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The level of high-density lipoprotein is thought to be critical in inhibiting lesion formation as well as reducing the lipid load of
preexisting atherosclerotic lesions. With the aim of determining the main determinants of plasma HDL-cholesterol (HDL-c) in
free-living adults, 997 individuals (52.3 ± 10 years, 67% females) were selected for a descriptive cross-sectional study. The used
data corresponded to the baseline obtained from participants clinically selected for a lifestyle modiﬁcation program. Covariables
of clinical, anthropometry, food intake, aerobic ﬁtness, and plasma biochemistry were analyzed against plasma HDL-c either as
continuous or categorized variables. After adjustments for age, gender, and BMI the excess of abdominal fat along with high
carbohydrate-energy intakeand altered plasma triglycerides were the stronger predictors of reduced plasma HDL-c. In conclusion
lifestyle interventions aiming to normalize abdominal fatness and plasma triglycerides are recommended to restore normal levels
of HDL-c in these free-living adults.
1.Introduction
It is now established that oxidation of LDL constitutes a key
event in inﬂammation and atherogenesis [1]. Mechanisms
of LDL oxidation in vivo involve concerted modiﬁcation
through oxidation by oxidants produced by arterial wall
cells, such as reactive nitrogen species, reactive chlorine
species, hydroxyl radicals, and lipid soluble free radicals
[2]. Such a spectrum of chemically diverse oxidants implies
that any single low-molecular weight antioxidant such as
vitamin E or C, even at physiologically relevant doses, may
not provide complete oxidative protection of LDL in vivo
[1, 2]. Atherogenic dyslipidemia is commonly characterized
by elevated triglycerides, normal or slightly elevated LDL-
cw i t har e d u c e dH D L - cc o n c e n t r a t i o n[ 3]. Plasma high-
density lipoprotein cholesterol (HDL-c) posses a spectrum
of antiatherogenic actions, including potent antioxidant
and anti-inﬂammatory activities [4]. The usual protective
features of high HDL-c are reverse cholesterol transport,
antioxidative, anti-inﬂammatory, antiapoptotic, antithrom-
botic, anti-infections, vasodilatation, and so forth [5].
Dietary and exercise modiﬁcations can lead to improve-
ment of HDL-c concentrations, which may be associated
with greater antioxidative role of HDL-c [6–9]. It has
been demonstrated that HDL-c concentrations are positively
associated with physical function in older adults [10].
IntheATTICAstudy,participantswhowhere morephys-
ically active and consumeda diet closerto theMediterranean
type showed higher values of HDL-c. Furthermore women
and those with lower BMI and younger age had higher HDL-
cv a l u e s[ 11].
The aim of this study was to determine the major
determinants of plasma HDL-c in free-living adultsclinically2 Cholesterol
selected for a lifestyle modiﬁcation program with physical
exercises.
2.Methods
2.1. Individuals. A descriptive cross-sectional study was
conducted in a subgroup of participants clinically screened
for the lifestyle modiﬁcation program “Mexa-se Pr´ o-Sa´ ude
(Move for Health)”, from 2002 to 2009. This program is
oﬀered to patients with noncommunicable chronic diseases
and consists of regular physical exercise and nutritional
counseling. The Metabolism, Exercise and Nutrition Cen-
ter (CeMENutri), conducts this program since 1992, in
Botucatu. Botucatu is a city located in the center of Sao
Paulo State, about 230km west of the capital city and has a
population of 121,274 in habitants [12].
The inclusion criteria for participants are individuals
over the age of 35, of both genders, with at least one of
the metabolic syndrome components and/or comorbities,
and without metabolic or motor disabilities that would limit
physical exercise.
The 1129 individuals that attended the program during
this period comprised 67% females and were 52.3 ± 10
y e a r so fa g e .A l lt h es u b j e c t ss i g n e daf r e ec o n s e n tf o r m ,
and the research project was approvedby the Research Ethics
Committee (document no. CEP 3271-2009) of the Botucatu
School of Medicine (FMB), S˜ ao Paulo State University
(UNESP), Brazil.
From those 1129 subjects, 997 had HDL-c data and
were studied. Data on clinical, ﬁtness, food consumption,
body composition, and plasma biochemistry were available
as indicated in the ﬂow chart (Figure 1).
2.2.DietaryIntake. Usualdietaryintakedatawasdetermined
using a 24-hour recall. The diet was documented by trained
personnel, and to obtain precise information, the subjects
were asked how often they usually ate during the day, what
variety of food was consumed, how the food was prepared,
what the serving size was, and what the brand of the
food/meal was. The diets were analyzed with the software
NutWin (2002) version 1.5 [13], and the principal nutrients
of interest were energy, protein, fat (saturated, mono- and
polyunsaturated), cholesterol, carbohydrates, and dietary
ﬁber. Mean individual nutrient intakes per day were com-
puted using the NutWin database and Brazilian food tables
[14–16]. The Healthy Eating Index (HEI) modiﬁed for the
Brazilian population was used to assess the quality of the
participant’sdiet[17].Theoriginal HEIwasdevelopedbased
on a 10-component system of ﬁve food groups with a total
possible index score of 100. This method was adapted for
the Brazilian population based on the Brazilian food guide
that has eight food groups and 12 components to measure
the variety of food intake. Each of the 12 components has a
score ranging from 0 to 10, so the total possible index score
is 120.
2.3. Anthropometry. Body weight was measured by a
platform-type anthropometric scale (Filizola) with a max-
imum capacity of 150kg and an accuracy of 0.1kg.
Height was determined by a portable Seca stadiometer
with an accuracy of 0.1cm [18]. Using body weight and
height measurements, BMI (weight/height (m2)w a sc a l c u -
lated.
Waist circumference (WC) was measured at the point
midway between the last rib and the iliac crest. A steel Sanny
anthropometric tape measure (without a lock) was used for
all measurements.
A bioelectrical impedance device (Biodynamics, model
450, USA)was used to determine body fat percentage (%BF)
[19] and body-muscle mass whose data were used for the
muscle-mass index (MMI) calculation [20].
2.4. Biochemical Analyses. Blood samples were collected by
vacuum venous puncture, after a 10- to 12-hour fasting
period. The individuals were previously advised to not
perform vigorous physical exercises 24-hours and/or con-
sume alcohol 72-hours prior to blood collection. Laboratory
analysis was performed within 4 hours after blood collection
using the dry-chemistry method (Vitros system, Johnson &
Johnson), plasma ultrasensititivity C-reactive protein (CRP)
was measured by immulite kit (DPC) Medlab-diagnostic
Products Corporation, Los Angeles, CA.
2.5. Cardiorespiratory Index (VO2max). The VO2max was
indirectly measured through the time spent in electrical
treadmill [21] during the Balke protocol [22].
2.6. Operational Deﬁnition of Variables. Overweight was
classiﬁed as BMI ≥25kg/m2 [23], alteredWC was considered
when above 102cm (40.16 inches) for men and above 88cm
(34.65inches) for women [24]. Sarcopenia was deﬁned by
muscle mass index (MMI) lower than 10.75kg/m2 for men
and below 6.75kg/m2 for women [25]. Higher body fat
was deﬁned by body fatness higher than 25% for men
and higher than 35% for women [26]. Hypertriglyceridemia
was deﬁned by plasma concentrations ≥150mg/dL [27],
lower HDL-c as <40mg/dL for men and <50mg/dL for
women [27]andhypercholesterolemiawas >200mg/dL[28].
Higher plasma glucose was deﬁned by ≥100mg/dL, higher
CRP by ≥0.3mg/dL, and higher uric acid when in the 4th
quartile.
2.7. Statistical Analysis. Statistical analyses were conducted
with SAS software for windows (SAS version 9.1.3., SAS
Institute, Inc., Cary, NC). Descriptive statistics were per-
formed for the study and continuous variables are presented
as means ± standard deviation (SD). Continuous variables
were comparedbytheWilcoxontest.Pearsoncorrelationwas
applied to observe the correlationship between HDL-c and
body composition, dietary consumption, and biochemistry
analysis.
Regression models for data with negative binomial
distribution were ﬁtted for food intake characterization. In
order to determine the probability of HDL-c alteration by
food intakes, anthropometry, and biochemical analysis, P<
.05 was adopted as a signiﬁcant value.Cholesterol 3
1129 individuals screened for the lifestyle
modiﬁcation program
997 individuals with plasma HDL-c value
983 individuals with body mass index
969 individuals with other plasma variables
476 individuals with all the metabolic syndrome components
449 individuals with dietary values





muscle-mass index, VO2maxand plasma albumin (Table 1).
Plasma HDL values correlated positively (P<. 05) with
age, total cholesterol, and albumin. They were negatively
correlated (P<. 05) with BMI, WC, ingested (%) protein,
cholesterol (mg/day), serving of legumes and meats, plasma
uric acid, LDL-c, glucose, TG, total protein, and DBP
(Figure 2). There was no signiﬁcant correlationship between
plasma HDL-c and the variables: body fat (%), MMI
(kg/m2), the energy contribution of ingested CHO, total
and saturated, mono- or polyunsaturated fat, ingested ﬁber,
and servings of grains, fruits, dairy, sugar, and oils, as well
as dietary variety and HEI. The correlationship was not
signiﬁcant also for values of plasma, CRP, and SBP.
Table 2 contains the odds ratio of reduced HDL-c in
function of abnormal anthropometry. Table 3 contains the
odds ratio for changed plasma variables and Table 4 for
the altered intake of dietary components. After adjustments
for sex, age, and BMI the waist circumference, along with
high CHO-energy intake and elevated plasma levels of
triglycerides were the stronger determinants of reduced
plasma HDL-c, whereas higher plasma cholesterol presented
ap r o t e c t i v ee ﬀect. By using the other four components of
metabolic syndrome (blood hypertension, waist circumfer-
ence and plasma triglycerides and glucose) for adjustments
the resulted odds ratio presented plasma triglycerides and
waist circumference as risk factor and plasma cholesterol as a
protective factor against low HDL-c plasma.
4.Discussion
From the dietary intake only meat, cholesterol, and legumes
correlated (negatively) signiﬁcantly with plasma HDL-c
concentrations. Diﬀerently of these data others had revealed
that dietary cholesterol increases the HDL-c level in women
[11]. Moreover they described that polyunsaturated fat and
the polyunsaturated/saturated lipid ratio decrease the HDL-
c level. Presently, we found that HDL-c was decreased by
intaking higher serving of meat, and also by the higher
protein-energy contribution. However, after the adjustments
for gender, age, BMI, and total energy intake (TEI) the
higher CHO intake was the only dietary risk factor found for
abnormal HDL-c.
Many recommendations have been provided to the
public to reduce dietary fat, with some claims that health
beneﬁt will be achieved [29]. However in human studies
when total fat is replaced by carbohydrate intake, the result
is a decreased plasma concentration of fasting HDL-c and
elevated triglycerides, which may counteract the beneﬁt of
lowering LDL-c. Therefore increasing carbohydrate intake
may adversely aﬀect lipoprotein concentrations as seen in
the present work. Park et al. also found in Korean women
thathighercarbohydrateintakesweresigniﬁcantlyassociated
with low HDL-c levels [30]. Additionally, signiﬁcantly lower
HDL-c were associated with sugar consumed by high BMI
A f r i c a nA m e r i c a nc h i l d r e n[ 31].
In 2006, the American Heart Association revised their
diet and lifestyle recommendations adding a recommenda-
tion to minimize intakes of beverages and foods with added
sugars [32].
Among the other lifestyle contributions to HDL-c levels
[11] no correlationships were found for VO2max and smok-
ing (plasma SCN levels), the alcohol consumption was not
assessed.
In a more comprehensive study (ATTICA study) Chryso-
hoou et al. [11] found that participants who were more
physically active and consumed a diet closer to the Mediter-
ranean type showed higher values of HDL-c. In the present
data neither diet quality (HEI)n or VO2max proved that
the studied sample was either physically active or on
Mediterranean-style diet.
As already referred by others [11]s u b j e c t sw i t hl o w e r
BMI had higher HDL-c levels. In the present data not only
BMI but all other markers of hyperadiposity were predictors4 Cholesterol
Table 1: Demographic, anthropometric, clinical, and laboratory characterization of individuals with normal and abnormal high density
lipoprotein cholesterol.
n Normal HDL n Abnormal HDL P
Age (years) 617 53.5 ± 9.8 366 52.5 ± 10.3 .09
Body Mass Index (kg/m2) 617 28.7 ± 5.3 366 30.0 ± 5.1 <.0001
Waist Circumference (cm) 613 93.9 ± 13.8 366 97.5 ± 12.8 <.0001
Body Fat (%) 472 31.4 ± 8.0 303 33.3 ± 8.9 .005
Muscle Mass Index (kg/m2) 380 10.9 ± 5.1 233 9.55 ± 4.5 .0004
Total Energy Intake (kcal) 615 1627 ± 604 371 1562± 614 .08
Carbohydrate (%) 615 51.2 ± 10.2 371 51.5 ± 10.1 .25
Protein (%) 615 18.5 ± 5.9 371 18.8 ± 5.9 .59
Fat (%) 615 30.3 ± 8.8 371 29.6 ± 8.6 .14
Saturated Fat (%) 283 8.7 ± 4.1 253 8.9 ± 3.9 .52
Monounsaturated Fat (%) 283 9.2 ± 3.6 253 9.1 ± 3.7 .63
Polyunsaturated Fat (%) 283 6.8 ± 3.2 253 6.5 ± 3.3 .20
Cholesterol (mg/day) 553 191 ± 142 329 193± 134 .56
Fiber (servings) 614 13.7 ± 7.3 369 13.5 ± 7.8 .30
Cereal (servings) 235 3.6 ± 2.0 221 3.5 ± 1.7 .58
Fruits (servings) 235 2.5 ± 2.8 221 2.2 ± 2.6 .12
Vegetables (servings) 235 2.6 ± 3.4 221 2.4 ± 2.5 .45
Legumes (servings) 235 1.1 ± 1.5 221 1.1 ± 1.5 .27
Dairy (servings) 235 1.4 ± 1.3 221 1.3 ± 1.2 .64
Meat (servings) 235 2.0 ± 1.7 221 1.9 ± 1.5 .83
Sugar (servings) 235 1.6 ± 1.9 221 1.5 ± 1.8 .63
Oil (servings) 235 2.5 ± 2.1 221 2.7 ± 7.9 .19
Variety (servings) 235 13.1 ± 4.2 221 12.6 ± 4.2 .22
Health Eat Index 235 80.3 ± 15.8 221 79.1 ± 14.8 .37
Plasma urea (mg/dL) 609 32.4 ± 10.4 365 32.6 ± 12.5 .74
Plasma creatinine (mg/dL) 612 0.94 ± 0.25 366 0.96 ± 0.21 .11
Plasma uric Acid (mg/dL) 609 4.53 ± 1.61 360 5.11 ± 1.48 <.0001
Plasma LDL-c (mg/dL) 580 127 ± 35.4 333 132± 37.0 .09
Plasma glucose (mg/dL) 612 101 ± 29.9 365 103± 35.1 .15
Plasma total Cholesterol (mg/dL) 614 216 ± 41.2 366 207± 39.9 .03
Plasma triglycerides (mg/dL) 584 142 ± 79.4 324 197± 140.61 <.0001
Plasma total Protein (g/dL) 548 7.3 ± 0.58 289 7.4 ± 0.66 .002
Plasma albumin (g/dL) 572 4.5 ± 0.5 313 4.3 ± 0.5 <.0001
Plasma c-Reactive Protein (mg/dL) 151 0.36 ± 0.46 105 0.58 ± 0.75 .001
VO2max 69 37.3 ± 9.8 45 33.3 ± 10.0 .03
Systolic blood pressure (mmHg) 342 128 ± 18.3 142 129± 15.4 .18
Diastolic blood pressure (mmHg) 342 81.1 ± 11.5 142 82.7 ± 10.4 .13
Table 2: Logistic regression analysis for the associationof reduced plasma HDL-c concentration with the anthropometric variables.
Model 1 Model 2 Model 3
Waist Circumference (abnormalversus normal) 1.697 (1.305–2.207) 1.712 (1.308–2.242) 1.40 (1.02–1.91)
Body Mass Index (abnormalversus normal) 1.901 (1.347–2.680) 1.941 (1.367–2.754) —
% Body Fat (abnormalversus normal) 1.398 (1.044–1.872) 1.436 (1.068–1.930) 1.24 (0.90–1.71)
Muscle Mass Index (abnormal versus normal) 1.113 (0.788–1.572) 1.190 (0.836–1.692) 1.42 (0.90–2.07)
Model 1 = crude
Model 2 = adjusted for sex and age
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Figure 2: Statistical signiﬁcant correlationships (P<. 05) found for plasma HDL-c concentrations.
Table 3: Logistic regression analysis for the associationof reduced plasma HDL-c concentration with the other blood markers.
Model 1 Model 2 Model 3 Model 4
Urea (abnormalversus normal) 1.097 (0.790–1.522) 1.152 (0.821–1.615) 1.166 (0.829–1.642) 0.940 (0.510–1.736)
Creatinine (abnormalversus normal) 1.692 (0.726–3.952) 1.821 (0.776–4.273) 1.736 (0.735–4.098) 1.057 (0.238–4.672)
Uric Acid (abnormal versus normal) 1.879 (1.302–2.717) 1.945 (1.335–2.832) 1.715 (1.164–2.525) 2.036 (0.995–4.166)
Glucose (abnormalversus normal) 0.933 (0.710–1.228) 0.968 (0.730–1.282) 0.879 (0.660–1.173) 0.638 (0.401–1.017)
Triglycerides (abnormal versus normal) 2.645 (1.996–3.496) 3.030 (2.257–4.081) 2.801 (2.070–3.787) 2.816 (1.776–4.464)
Albumin (abnormal versus normal) 0.729 (0.140–3.787) 0.689 (0.131–3.597) 0.710 (0.135–3.717) —
C-Reactive Protein (abnormal versus normal) 1.769 (1.070–2.932) 1.706 (1.018–2.857) 1.367 (0.794–2.358) 1.689 (0.747–3.816)
Total Cholesterol (abnormalversus normal) 0.643 (0.492–0.840) 0.664 (0.506–0.872) 0.656 (0.498–0.864) 0.453 (0.278–0.736)
LDL-c (abnormal versus normal) 1.035 (0.790–1.355) 1.094 (0.832–1.438) 1.091 (0.828–1.436) 1.109 (0.708–1.739)
Model 1 = crude
Model 2 = adjusted for sex and age
Model 3 = adjusted for model 2 and Body Mass Index
Model 4 = adjusted for model 3 and systolicblood pressure, diastolic blood pressure, waist circumference, triglycerides,glucose.
of reduced HDL-c levels. From those markers only WC
remained as independent risk factors for lower HDL-c.
Changed plasma values of uric acid, triglycerides, and
CRPweresigniﬁcant risk factors foralteredHDL-cevenafter
gender and age adjustments. However, only high plasma uric
acid and triglycerides persisted after the BMI adjustment.
Furthermore only triglycerides represented an independent
plasma risk factor for altered HDL-c after adjustments
including the remaining components of metabolic syn-
drome.
Thus, the found independent risk factors for reduced
HDL-c were higher dietary energy contribution of CHO,
higher WC, and higher plasma triglycerides.
In the present work higher CRP functioned as a risk
factorforlowerHDL-cuntiltheadjustmentforBMI.Obesity
i sk n o w na sa ni n ﬂ a m m a t o r yd i s e a s e[ 33]w h i c hm i g h t
decrease HDL-c concentrations [34].
The present data shows altered uric acid as a predictor
of reduced HDL-c. Higher uric acid and low-grade inﬂam-
mation are associated with impaired lipoprotein metabolism
even before clinically visible symptoms of atherosclerosis are
apparent [3].
Uric acid may function as a potent antioxidant by
scavenging free radicals and also by stabilizing ascorbate in
biological ﬂuids [35]. Therefore elevated uric acid could be
considered to be a compensatory mechanism that counter-
actsoxidativestress related tothepreponderanceofimpaired
HDL particles [3].
The main limitation of our study resides in its cross-
sectional design. Given the study design, we could not6 Cholesterol
Table 4: Logistic regression analysis for the associationof reduced plasma HDL-c concentration with the dietary intake parameters.
Model 1 Model 2
%C H O( ≥50% VERSUS <50%) 1.258 (0.958–1.636) 1.373 (1.046 – 1.803)
%P r o t e i n( ≤15% VERSUS >15%) 0.916 (0.689–1.218) 0.982 (0.731–1.318)
%F a t( <35% VERSUS ≥35%) 1.188 (0.883–1.599) 1.238 (0.907–1.690)
% Saturated fat (≤10 VERSUS >10%) 1.045 (0.731–1.493) 1.082 (0.747–1.568)
% Monounsaturated fat (≤20% VERSUS >20%) 1.799 (0.327–9.906) 1.876 (0.311–10.642)
% Polyunsaturated fat (≤10 VERSUS >10%) 1.229 (0.740–2.040) 1.183 (0.705–1.984)
Cholesterol (<200mg VERSUS >200mg) 1.005 (0.683–1.478) 1.012 (0.666–1.536)
Cereals (≥5V E R S U S<5 servings) 0.861 (0.540–1.374) 1.129 (0.665–1.916)
Fruits (≥3V E R S U S<3 servings) 0.845 (0.574–1.246) 0.903 (0.604–1.351)
Vegetables (≥4V E R S U S<4 servings) 1.041 (0.665–1.620) 1.033 (0.643–1.653)
Legumes (≤2V E R S U S>2 servings) 1.123 (0.777–1.621 ) 1.223 (0.823–1.816)
Dairy (≥3V E R S U S<3 servings) 0.911 (0.529–1.569) 1.100 (0.563–1.812)
Meat (≤2V E R S U S>2 servings) 0.988 (0.678–1.470) 0.905 (0.583–1.400)
Oil (≤2V E R S U S>2 servings) 0.728 (0.499–1.061) 0.797 (0.521–1.220)
Variety (≥8V E R S U S<8) 0.697 (0.288–1.688) 0.803 (0.326–1.976)
Fiber (≥20g VERSUS <20g) 0.988 (0.708–1.406) 1.168 (0.810–1.682)
Health Eat Index (>100 VERSUS ≤100 points) 0.768 (0.399–1.480) 0.664 (0.330–1.337)
Model 1 = crude
Model 2 = adjust for sex, age, total energy intake and body mass index.
investigate any cause-eﬀect mechanism for the studied
relationships but only generate hypothesis. Secondly, the
study sample size was relatively small which could limit
the generalization of our results. Finally, the fact that the
subjectsvolunteeredforthelifestylechanging programcould
have introduced a selection bias. Also we cannot completely
rule out possible inaccuracy in one-day 24 hour-food intake
recall.
5.Conclusions
This study highlights the inverse relationship between HDL-
c levels and higher intake of carbohydrates, along with
excess of abdominal adiposity and higher plasma levels
of triglycerides. These associations may confer a further
prescription of lifestyle changing program for improving
dietary intake, physical ﬁtness, and body fatness.
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